Trial intelligence / Profile preview

Ezetimibe in Homozygous Sitosterolemia

NCT00092807Phase 3Completed

Sponsor
Organon & Co.
Start
Feb 2001
Primary completion
Sep 2001
Modality
Small Molecules
01

Overview

A Phase 3 trial of ezetimibe in sitosterolemia, sponsored by Organon & Co.. Started Feb 2001; status: completed.

02

Drugs

ezetimibe
03

Conditions

sitosterolemia

Beyond the preview

Go deeper on NCT00092807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00092807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call